Rebecca Byam, Chief Financial Officer at HCW Biologics Inc. (HCWB), bought 8,462 shares at $26.00 ($220K) on 2025-05-08, disclosed to the SEC on 2025-05-09.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| HCWB | BUY | 2023-09-13 | $21K | — | Filing → |
| HCWB | BUY | 2023-09-08 | $20K | — | Filing → |
| HCWB | BUY | 2023-09-07 | $10K | — | Filing → |